Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: A 9-year retrospective study at a single institution

Journal of the American Academy of Dermatology

Volumn 43, Issue 2 I, 2000, Pages 263-271

  Bisaccia, Emil ^a,b   Gonzalez, Joselyn ^b   Palangio, Mark ^a   Schwartz, Joseph ^b   Klainer, Albert S ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; METHOXSALEN; PREDNISONE; RECOMBINANT ALPHA INTERFERON; RETINOID; STEROID; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PUVA; QUALITY OF LIFE; SKIN LYMPHOMA; T CELL LYMPHOMA; TREATMENT OUTCOME; WELLBEING;

EID: 0033863053     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.104852     Document Type: Article

References (29)

1. Cutaneous T-cell lymphoma
2. Prognostic factors and evaluation of mycosis fungoides and Sezary syndrome
3. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: Preliminary results
4. Photopheresis for the treatment of cutaneous T-cell lymphoma
5. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy
6. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: The Dusseldorf and Munich experience
7. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alpha: A 10-year experience at a single institution
8. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy
9. Photopheresis therapy for cutaneous T-cell lymphoma
10. Extracorporeal photopheresis and interferon-α in advanced cutaneous T-cell lymphoma
11. Proceedings of the workshop on cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)
12. Prognosis and staging of cutaneous T-cell lymphoma
13. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sezary syndrome)
14. Treatment of cutaneous T-cell lymphoma
15. Reporting results of cancer treatment
16. Assessing clinical outcomes in cutaneous T-cell lymphoma
17. Mechanistic events underlying the response of CTCL patients to photopheresis
18. Extracorporeal photochemotherapy in a patient with Ki-1-positive anaplastic large-cell lymphoma
19. Cutaneous T-cell lymphoma, tropical spastic paraparesis, cerebral vasculitis, and protein S deficiency in a patient with HTLV-1
20. Mycosis fungoides: Clinical staging and histological features, staging, evaluation, and approach to treatment
21. Histologic staging at initial diagnosis of mycosis fungoides and Sezary syndrome
22. Prospective staging evaluation of patients with cutaneous T-cell lymphomas: Demonstration of a high frequency of extracutaneous dissemination
23. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides
24. Proceedings of the international consensus conference on cutaneous T-cell lymphoma (CTCL) treatment recommendations, Boston, Massachusetts, Oct 1 and 2, 1994
25. Photopheresis in the 1990's
26. Specific suppression of anti-allograft immunity by vaccination with syngeneic photoactivated splenocytes
27. Tumor-specific peptides in cutaneous T-cell lymphoma: Association with class I major histocompatibility complex and possible derivation from clonotypic T-cell receptor
28. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action
29. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-α by monocytes: Implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis